Vimarsana
Biggest News Aggregation in the World

Quest Pharmaceutical Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quest Pharmaceutical Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quest Pharmaceutical Services Today - Breaking & Trending Today

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement - Vimarsana News

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

Published: July 28, 2023

28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report ...

Source: wallstreet-online.de
Related Topics:
South AustraliaUnited StatesNew ZealandJoel LathamRedomiciling IncannexPeter WiddowsApril IncannexDrug AdministrationEarly Phase Clinical ResearchIncannex HealthcareClinical ResearchIv Clinical ResearchQuest Pharmaceutical ServicesClarion Clinics Group Pty LtdHuman Research Ethics CommitteeClarion Clinics GroupEuropean Union Medicines AgencyCorporate Governance Council PrinciplesDisclosure CommitteeApirx PharmaceuticalsIncannex Healthcare IncObstructive Sleep ApnoeaObstructive SleepInvestigational New DrugTrial Investigating
Incannex Healthcare Ltd appoints QPS to advance nicotine and opioid addiction treatment and Renecann™ products in the US and EU - Vimarsana News

Incannex Healthcare Ltd appoints QPS to advance nicotine and opioid addiction treatment and Renecann™ products in the US and EU

Published: April 14, 2023

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has secured the aid of Quest Pharmaceutical Services to provide regulatory advice and manage clinical trials...

Source: proactiveinvestors.com
Related Topics:
United StatesJoel LathamEarly Phase Clinical ResearchQuest Pharmaceutical ServicesIv Clinical ResearchIncannex Healthcare LtdEuropean Union Medicines AgencyDrug AdministrationTranslational MedicineEuropean UnionEuropean Medicines Agency
Date: April 14, 2023 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K - Vimarsana News

Date: April 14, 2023 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K

Published: April 14, 2023

Date: April 14, 2023 Public Announcement Incannex Appoints QPS to Advance... | April 14, 2023

Source: marketscreener.com
Related Topics:
United StatesJoel LathamMarcus MeinardiApirx PharmaceuticalsEuropean Union Medicines AgencyIncannex Healthcare Ltd NasdaqCentre For Disease ControlEdison GroupAustralian Stock ExchangeIv Clinical ResearchEarly Phase Clinical ResearchIncannex HealthcareMarket ResearchQuest Pharmaceutical ServicesIncannex Healthcare LimitedDrug AdministrationAdvance Cannquit NHealthcare LtdTranslational MedicineEuropean UnionEuropean Medicines AgencyManaging DirectorHealthcare LimitedRialto South TowerDisease Control